Specificity protein 1-modulated superoxide dismutase 2 enhances temozolomide resistance in glioblastoma, which is independent of O6-methylguanine-DNA methyltransferase
- Kwang Yu Chang
- , Tsung I. Hsu
- , Che Chia Hsu
- , Shan Yin Tsai
- , Jr Jiun Liu
- , Shao Wen Chou
- , Ming Sheng Liu
- , Jing Ping Liou
- , Chiung Yuan Ko
- , Kai Yun Chen
- , Jan Jong Hung
- , Wen Chang Chang
- , Cheng Keng Chuang
- , Tzu Jen Kao
- , Jian Ying Chuang
- Ph.D. Program in Medical Neuroscience
- Department of Pharmaceutical Sciences
- Ph.D. Program in Drug Discovery and Development Industry
- Graduate Institute of Medical Sciences
- TMU Research Center of Cancer Translational Medicine
- International Master Program in Medicine
- TMU Research Center of Drug Discovery
- TMU Research Center of Cell Therapy and Regeneration Medicine
- International Ph.D. Program in Cell Therapy and Regenerative Medicine
- TMU Research Center of Neuroscience
- TMU Research Center of Thoracic Medicine
- Ph.D. Program for Cancer Molecular Biology and Drug Discovery
- Ph. D. Program in the Clinical Drug Development of Herbal Medicine
- International Master Program in Medical Neuroscience
Research output: Contribution to journal › Article › peer-review
66
Link opens in a new tab
Citations
(Scopus)